Guardian Pharmacy Services, Inc. (GRDN) Stock Forecast
Data as of Aug 1, 2026Healthcare · Current price $39.48 (-4.34%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 12, 2026 | John Ransom | Raymond James | $40.00 | +1.3% |
| Mar 12, 2026 | David MacDonald | Truist Financial | $38.00 | -3.7% |
| Jan 14, 2026 | Raj Kumar | Stephens | $36.00 | -8.8% |
| Sep 26, 2025 | David MacDonald | Truist Financial | $30.00 | -24.0% |
| May 14, 2025 | John Ransom | Raymond James | $28.00 | -29.1% |
Top Analysts Covering GRDN
GRDN vs Sector & Market
| Metric | GRDN | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.00 | 2.25 | 2.42 |
| Analyst Count | 6 | 8 | 19 |
| Target Upside | +10.2% | +16316.2% | +17.1% |
| P/E Ratio | 47.57 | 2.97 | 43.33 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $359M | $362M | $365M | 1 |
| 2026-12-31 | $377M | $380M | $383M | 2 |
| 2027-03-31 | $356M | $359M | $361M | 1 |
| 2027-06-30 | $368M | $371M | $374M | 2 |
| 2027-09-30 | $392M | $395M | $398M | 2 |
| 2027-12-31 | $410M | $414M | $417M | 1 |
| 2028-12-31 | $1.66B | $1.68B | $1.70B | 2 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-09-30 | $0.30 | $0.30 | $0.30 | 1 |
| 2026-12-31 | $0.41 | $0.42 | $0.42 | 1 |
| 2027-03-31 | $0.26 | $0.27 | $0.27 | 1 |
| 2027-06-30 | $0.29 | $0.29 | $0.30 | 1 |
| 2027-09-30 | $0.33 | $0.34 | $0.34 | 1 |
| 2027-12-31 | $0.45 | $0.45 | $0.46 | 1 |
| 2028-12-31 | $1.44 | $1.46 | $1.48 | 2 |
Frequently Asked Questions
What is the analyst consensus for GRDN?
The consensus among 6 analysts covering Guardian Pharmacy Services, Inc. (GRDN) is Buy with an average price target of $43.50.
What is the highest price target for GRDN?
The highest price target for GRDN is $40.00, set by John Ransom at Raymond James on 2026-03-12.
What is the lowest price target for GRDN?
The lowest price target for GRDN is $28.00, set by John Ransom at Raymond James on 2025-05-14.
How many analysts cover GRDN?
6 analysts have issued ratings for Guardian Pharmacy Services, Inc. in the past 12 months.
Is GRDN a buy or sell right now?
Based on 6 analyst ratings, GRDN has a consensus rating of Buy (2.00/5) with a +10.2% upside to the consensus target of $43.50.
What are the earnings estimates for GRDN?
Analysts estimate GRDN will report EPS of $0.30 for the period ending 2026-09-30, with revenue estimated at $362M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.